DekaBank Deutsche Girozentrale’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,350	Closed	-$468K	–	1437
2022 Q1	$468K	Buy	17,350 +480	+3%	+$16.1K	﹤0.01%	1071
2021 Q4	$789K	Buy	16,870 +400	+2%	+$17.9K	﹤0.01%	990
2021 Q3	$1.12M	Hold	16,470	–	–	﹤0.01%	877
2021 Q2	$1.25M	Hold	16,470	–	–	﹤0.01%	860
2021 Q1	$1.47M	Buy	16,470 +1,120	+7%	+$133K	﹤0.01%	781
2020 Q4	$1.85M	Sell	15,350 -7,250	-32%	-$794K	0.01%	686
2020 Q3	$2M	Buy	+22,600	New	+$1.57M	0.01%	592

Other funds holding TPTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TPTX Position: Q2 2022 in Review

DekaBank Deutsche Girozentrale sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 17,350 shares — an estimated $468K sold.

DekaBank Deutsche Girozentrale first reported a position in TPTX in Q3 2020 and held it in 7 quarters. The position peaked at $2M in Q3 2020. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

DekaBank Deutsche Girozentrale reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 17,350 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $468K.
DekaBank Deutsche Girozentrale first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's Turning Point Therapeutics, Inc. Common Stock position peaked at $2M in Q3 2020.
208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.